SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-20-015833
Filing Date
2020-04-08
Accepted
2020-04-08 09:14:24
Documents
14
Period of Report
2020-04-08
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K CORONAVIRUS BUSINESS UPDATE mygn-8k_20200408.htm   iXBRL 8-K 44835
2 EX-99.1 mygn-ex991_31.htm EX-99.1 15399
3 GRAPHIC gntubyjizugj000001.jpg GRAPHIC 4299
  Complete submission text file 0001564590-20-015833.txt   199732

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA mygn-20200408.xsd EX-101.SCH 5768
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE mygn-20200408_lab.xml EX-101.LAB 18734
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mygn-20200408_pre.xml EX-101.PRE 11169
14 EXTRACTED XBRL INSTANCE DOCUMENT mygn-8k_20200408_htm.xml XML 3414
Mailing Address 320 WAKARA WAY SALT LAKE CITY UT 84108
Business Address 320 WAKARA WAY SALT LAKE CITY UT 84108 801-584-3600
MYRIAD GENETICS INC (Filer) CIK: 0000899923 (see all company filings)

IRS No.: 870494517 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 000-26642 | Film No.: 20781266
SIC: 2835 In Vitro & In Vivo Diagnostic Substances